Dr. Fei Gao 高飞
Chief Physician
Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive interventional treatment for liver cancer with portal hypertension, including TIPS and recanalization of complex portal vein occlusion. Also performs radiofrequency/microwave ablation, particle implantation, biliary stenting for malignant obstructive jaundice, and intracavitary brachytherapy.
Dr. Gao is Deputy Department Director and Chief Physician at Sun Yat-sen University Cancer Center, holding a PhD from Sun Yat-sen University and postdoctoral experience from the University of Rochester. With over 20 years in interventional oncology, Dr. Gao has published over 60 papers and contributed to Chinese clinical practice guidelines for TIPS.
Professional roles
- Vice Chair, Youth Committee, Interventional Physicians Branch, Chinese Medical Doctor Association
- Secretary-General, Professional Committee on Minimally Invasive Tumor Therapy, China Anti-Cancer Association
- Standing Committee Member, China Venous Interventional Alliance
- Youth Committee Member, Interventional Group, Radiology Branch, Chinese Medical Association
Name order: in Chinese the family name comes first (Gao Fei). Papers usually list the name as Fei Gao or Gao F.
Selected publications
65 papers on PubMed matched by name and affiliation; 27 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Gastrointest Oncol, 2026 (senior author): Self-expandable metal stent (SEMS) with iodine-125 intraluminal brachytherapy versus SEMS alone for unresectable malignant distal biliary obstruction: survival and patency analysis. PubMed 42996843
- Radiol Oncol, 2026 (senior author): Erratum: CT-guided (125)I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study. PubMed 42831275
- Int J Surg, 2026 (senior author): A predictive model for optimal CT-guided thermal ablation margins in liver malignancies ≤3 cm: a retrospective cohort study. PubMed 41537283
- Cancer Lett, 2025 (senior author): Transarterial chemoembolization combined with intra-arterial infusion of sintilimab and bevacizumab for advanced hepatocellular carcinoma: a phase 2 study. PubMed 40472923
- Hepatology, 2025 (senior author): Letter to the Editor: Reflections on the predictors of long-term transplant-free survival after TIPS. PubMed 40577233
- Eur Radiol, 2025 (senior author): Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis. PubMed 40244406
- Jpn J Radiol, 2024 (senior author): Utilizing a suture-constrained covered stent for shunt reduction to treat transjugular intrahepatic portosystemic shunt-related refractory hepatic encephalopathy: a retrospective study. PubMed 38922569
- Cell Death Dis, 2024 (senior author): Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation. PubMed 39384740
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion